The skyrocketing popularity of weight-loss drugs like Ozempic and Wegovy has begun to take a financial toll on the alcohol ...
The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.
23hon MSN
President-elect Donald Trump’s threat to slap Denmark with tariffs to force its hand in giving up Greenland could lead to ...
The Biden administration is expected to release the next batch of drugs that will be subject to Medicare price negotiations — ...
President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.
A new request by Ozempic manufacturer Novo Nordisk could limit the availability of a type of GLP-1—semaglutides—to local ...
GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...
Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback